Key result
Intracoronary nitroglycerin reverses severe paclitaxel-induced coronary vasospasm mimicking STEMI.
Why the study?
Paclitaxel is associated with rare but potentially life-threatening cardiovascular toxicity including coronary vasospasm that can mimic STEMI and cause hemodynamic instability.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Paclitaxel can precipitate severe coronary vasospasm mimicking STEMI, which can be effectively diagnosed and treated with intracoronary nitroglycerin.
BACKGROUND: Paclitaxel is a widely used chemotherapeutic agent with rare but potentially life-threatening cardiovascular toxicity. CASE SUMMARY: A 58-year-old woman developed chest discomfort and syncopized within minutes of receiving her first paclitaxel infusion for recurrent cervical adenocarcinoma. Electrocardiography demonstrated inferior ST-segment elevation with reciprocal changes concerning for inferior-posterior ST-segment elevation myocardial infarction (STEMI). Despite near-complete electrocardiographic resolution, emergent coronary angiography was pursued and revealed severe diffuse coronary vasospasm without obstructive disease. Administration of intracoronary nitroglycerin resulted in prompt angiographic vasodilation, normalization of electrocardiographic changes, and hemodynamic stabilization. Transthoracic echocardiography demonstrated preserved biventricular systolic function. DISCUSSION: Paclitaxel-associated coronary vasospasm is capable of mimicking a STEMI and requires immediate angiographic assessment despite electrocardiogram resolution, especially when clinical instability is present. TAKE-HOME MESSAGES: Paclitaxel can precipitate abrupt, severe coronary vasospasm with shock physiology. Intracoronary nitroglycerin is a low-risk, high-yield intervention that confirms the diagnosis, excludes alternative STEMI mimics, and provides immediate therapy.
No takes yet. Share an insight, caveat, or question.
Chattha et al. (2026) conducted a case report in Paclitaxel-associated coronary vasospasm (n=1). Paclitaxel was evaluated on Coronary vasospasm with transient ST-segment elevation and hemodynamic instability. Paclitaxel infusion precipitated abrupt, severe coronary vasospasm mimicking STEMI with shock physiology, which was successfully treated with intracoronary nitroglycerin.
Synapse has enriched 10 related papers. Consider them for comparative context: